Evidence
We draw a hard line between three different kinds of claim: published clinical decision tools, our own models (not yet independently validated), and forward-looking design targets. Here's exactly where that line sits.
1. Published clinical decision tools we apply
The symptom-check assessment is instructed to apply these published, widely used clinical decision rules where relevant to a patient's presentation — they are the validated part of this product, not something we invented:
2. Our own models: shadow-mode only, not yet validated
JegsMediScan's own risk-scoring and admission-prediction models have never influenced a real patient's ESI level, routing, or care. They run only in shadow mode — evaluated against already-triaged real patients' outcomes, purely for internal review, with no path to a live recommendation until a clinical team signs off on a go/no-go review. Shadow evaluation can measure agreement with an ED's own actual triage decisions; it cannot, by itself, prove the model would have caught something a clinician missed. That requires a real clinical validation study, which hasn't been run.
3. Design targets are projections, not measured results
Numbers like reduced door-to-triage time or a lower left-without-being-seen rate, shown elsewhere on this site, are explicitly labeled design targets — goals the product is built toward, not outcomes measured at a live site. No hospital has deployed this product's hardware-sensor concept yet, so there is no live-site data to report.